Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay
<p>Abstract</p> <p>Background</p> <p>We aimed to combine the generation of "artificial" antibodies with a rat pituitary bioassay as a new strategy to overcome 20 years of difficulties in the purification of gonadotrophin surge-attenuating factor (GnSAF).</p...
Saved in:
Main Authors: | Mason Helen D (Author), Sorsa-Leslie Tarja (Author), Harris William J (Author), Fowler Paul A (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2005-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gonadotrophins: The future
by: Madhuri Patil
Published: (2014) -
Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022) -
Gonadotrophin releasing hormone antagonist in IVF/ICSI
by: M S Kamath, et al.
Published: (2008) -
Evolution of phage display libraries for therapeutic antibody discovery
by: Yang Zhang
Published: (2023) -
The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
by: Li Chen, et al.
Published: (2023)